Insider · CIK 0001823894
Mahatme Ujwala
Reports to the SEC for 1 company · CAMBRIDGE, MA
Transactions
7
Companies
1
Filings
4
CIK
0001823894
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-01-02 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2024-01-02 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | +$69.4K |
| 2023-01-03 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2023-01-03 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | +$67.6K |
| 2022-01-03 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2022-01-03 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | +$54.1K |
| 2021-02-19 | SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Mahatme Ujwala0001599298-24-000010SEC(opens sec.gov)
- 4Mahatme Ujwala0001599298-23-000006SEC(opens sec.gov)
- 4Mahatme Ujwala0001599298-22-000007SEC(opens sec.gov)
- 4Mahatme Ujwala0000921895-21-000542SEC(opens sec.gov)
Companies
Address
C/O SUMMIT THERAPEUTICS INC., ONE BROADWAY, 14TH FLOOR
CAMBRIDGE, MA, 02142